STRS Ohio’s Vor Biopharma VOR Stock Holding History

STRS Ohio’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$904K	Buy	+47,400	New	+$1.01M	﹤0.01%	935
2022 Q2	–	Sell	-135	Closed	-$16K	–	2305
2022 Q1	$16K	Hold	135	–	–	﹤0.01%	2063
2021 Q4	$31K	Hold	135	–	–	﹤0.01%	2064
2021 Q3	$42K	Hold	135	–	–	﹤0.01%	2097
2021 Q2	$50K	Hold	135	–	–	﹤0.01%	2109
2021 Q1	$116K	Buy	+135	New	+$114K	﹤0.01%	1916

Other funds holding VOR

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

STRS Ohio's VOR Position: Q3 2026 in Review

STRS Ohio opened a new position in Vor Biopharma (VOR) in Q3 2026: 47,400 shares worth $904K. The stake represents ﹤0.01% of the portfolio and ranks #935 among its holdings. This is a return to the name: STRS Ohio previously reported a position in VOR as recently as Q1 2022.

STRS Ohio first reported a position in VOR in Q1 2021 and has held it in 6 quarters since. 24 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

STRS Ohio held 47,400 shares of Vor Biopharma worth $904K as of Q3 2026.
Vor Biopharma was a new STRS Ohio position in Q3 2026.
Vor Biopharma made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #935 holding.
STRS Ohio first reported a position in Vor Biopharma in Q1 2021 and has held it in 6 quarters since.
24 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.